{"name":"AKL Research and Development","slug":"akl-research-and-development","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"APPA","genericName":"APPA","slug":"appa","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"APPA","genericName":"APPA","slug":"appa","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxPSXIwNlY4QXpwM1pSTThkajRZenBRWVFPMkVhYW45TkNVX2F3bUlFRFkyQmNTaHpPYy1xdlZTWXk2bHlJNkdNY3ZtR0hzb0NDbzFfMzBlRG5fUnhVSkxYU2lvNFpXM0FIWDNKWk9xWW1wR19qTFJUZExFOXZrdTVHbnVzNC1EemlkWnE2WXl0b0tnS1d5bjRsSWR3cVh4cnZ2Q2dRVVo3SXNLMC11dmJzWjRDeG1GY0FHdGtFNVVTcFNKZ09uNDVZWDl3RlVqdk5lSVJiSkdfbUY3bUUxQlJZLVhQaXZ2dzZLTzFWaXZwbkpCM2U4OThFU1JMSElnWE1ZTnc?oc=5","date":"2026-04-01","type":"trial","source":"Barchart","summary":"Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart","headline":"Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOZlJiMnRjTzZuTGFPQUdmU2g1UEpFdnE0YVJuS1ozOHpFYWFWc19rNHFRNkF6Z1dYX2dPSzJrVDNsOE5RSXh3NFZzWFlMdHotR2xURzFPaW81ZUZacGdsNFNXS1piWElJaHdPcTZLWWpNeUc1SzZjNzFQa2lkQlRWOGk4aDhOYml5aTJCTUhha0J2R3ZCdmRoOWZhMTVNNXVwMzVzak1ibEF0VkFTOTVRZGIzc0diQURWNEpIMzI0SlRuUWhCSzM2MXRjSkFheklGczU4UmNaZVN3WmZFZnRLTG5ZTU5BU2ZkRjlHb2JOTmkwUWl1Tl9IdjR5X3d3bGV0YXkwM1FCei1uMVpEa1FCSkxHaUVkMHlRdW9FcFo0R0plRWpLcnVZWUw2aEluWXRlYUE?oc=5","date":"2025-04-24","type":"trial","source":"globenewswire.com","summary":"Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ - globenewswire.com","headline":"Sarcopenia Clinical Trial Pipeline Appears Robust With 18+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxNVEJwUGRkeHZzLVdhaV9RRmdGbThzM0hHc0RTOTR0dzdtZUZYb1hQckhxMDNGRDVMem1rOVBkRm5ldERIN0xSY18xMXc1MGtOWW9QQVZrWDBBZ24xblFjRjhlaTg5MTVPU3hEUmNBNUJUZUFLTloyTGdvTkFpX1FiM0l2ajQ4U05zamtUZWpZSHhjaXRUeDFTVExtMUVTV1FsVno3TmFCREdLb0JiOU1IV3gxLTRrNmlNYnZtWmxNcDkzT1ZvMG9xd01zYWNNTGpGeUJEb2txcU9XR3JNNFZweGRyUUUwYTFIeFd3?oc=5","date":"2024-11-14","type":"pipeline","source":"globenewswire.com","summary":"Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight - globenewswire.com","headline":"Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2024-06-27","type":"pipeline","source":"PR Newswire","summary":"Systemic Sclerosis Market to Exhibit Significant Growth by 2034, Predicts DelveInsight | Key Companies - Kyowa Hakko Kirin, AstraZeneca, Mitsubishi Tanabe Pharma, Genentech, Amgen, GlaxoSmithKline, Bo","headline":"Systemic Sclerosis Market to Exhibit Significant Growth by 2034, Predicts DelveInsight | Key Companies - Kyowa Hakko Kir","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5DRm9BbnRUR2dSR0Jsa1hLZTFXY2JWc1NTN1JWR0tIZTYxUGVLUG5YNE5mTGpWQzB4T1BEakxvNERKbU5wZEMtVGgzd2E2eS00LVlacTJB?oc=5","date":"2024-06-21","type":"pipeline","source":"Xpert.Digital - Konrad Wolfenstein","summary":"The biotech or biopharma cluster in southern Germany based in Ulm is both a success story and a hidden champion at the same time - Xpert.Digital - Konrad Wolfenstein","headline":"The biotech or biopharma cluster in southern Germany based in Ulm is both a success story and a hidden champion at the s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQLXJ0V3RXckl3WXFyaTBoOTBoR3ozN1ZUd0E0U2NZU1JiblViTlZRWlhHbnNhdHppVUZfQmxpSlgtSTJrRHJhUXZoQ0RlelBPTEpRckZCeGFOcUptVTlGNkRFS1ZXNzd6OEU3ell2T01NUTk0MWduN0xBeV81QnZiWXJxMldIWTRlZVRGM0Mwai1JbE9FYURuUTFKYmZYbmtSTUQ4UjhUa0dJTHlMY2cxNnQ0UGZNZm1aTlYwZ1N0bFFkdXZ6YmhCLUdDSkdoVXhwaGo4ZmRaOGpuWlB4T3ZVTy1va2VhaUVTSEJtS3pMaHVhUGl5?oc=5","date":"2022-11-28","type":"pipeline","source":"European Medical Journal","summary":"Proactive Risk Management: A Novel Approach to Embedding Oral Corticosteroid Stewardship into Asthma Care - European Medical Journal","headline":"Proactive Risk Management: A Novel Approach to Embedding Oral Corticosteroid Stewardship into Asthma Care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxQSHNWUWtnNVkzOVJiQkdoay0xV1RTOXpSWFY0Nkp2Y2xRTkt6ckpwTUplc1dqTDhaX2g4MFdrTUwwb2FOQlZ0U3A1TjR3cUIxWGt4UzAxaFlIUUFhMmxSdGJSUWVyQk5jbUtJTTk3T2ltN29nN2Z0cldCaTBPWUlkQS12UTVNMy0zNUNqeVBYUm5DMHh5ZmFja1JVQ0FOcGJGX1dNZXZIdHlScnZRN1hBaDdXMFN0WERaT2d0LXE1RGl5dXhRdkpfd1p1Zm52WmZMUE5zZjl4Xy1VNGllQ2xZcTc4RHFDVThwbzhiQlJmdnNnZ0ZZNVBRLUtwYmhobUpOcjkxbTBBbXk2QVZvWi01bzM0UUs?oc=5","date":"2021-09-29","type":"trial","source":"FinancialContent","summary":"PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan - FinancialContent","headline":"PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOY2ttNUFBQ3VDMnpoSXhXb2ZaVlA4TUd5c0VEYk1KajQtU0lIbHZHWW1Vckx3SGlxUEJqRTJ2ODkwMnp4bE5DdlRlUHJrV3oxaWxTdmFYUkM1aWR3a3JGMjlvcl81aEs4ZS1LWXlfT1l3WkFSd0M2RERtQVc0UkE4WDVfYmVYdXU5MU5LcVBKRmlROG5QZmR6aFdMY0ZaSEp0Y25HRzhndWhLamFhRFI1T29GclBIcjY5cjYxdGhIcEpDVld1SnVqUzE5Z3pPVlFvclUtcDIyVQ?oc=5","date":"2020-11-13","type":"pipeline","source":"European Medical Journal","summary":"Novartis Virtual Asthma Theatre: Reconsidering the Potential of Inhaled Therapies in Asthma - European Medical Journal","headline":"Novartis Virtual Asthma Theatre: Reconsidering the Potential of Inhaled Therapies in Asthma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPSG1aeGwwanRYUTFOQnhCQU5WV2Z4Q2hzQmlqUnVjWHR4Vmo3OUtvOXBKclpBVXM5clowNUZwb1pnRFgtUzZpV19TeXJHaG1OTjRrX0hxZWpLdzZvUktqVFdjMXdNNDZPeW1sd3JRU0ZnSU1GWS1JYnN4VXR1QTh3VzV1ZTFTa2VwQXVyZk5uNjFtNjJVSWtuVlNSVlNUa3lodzBOV1RDNlBwbGgwd3c?oc=5","date":"2020-06-11","type":"trial","source":"Medical News Today","summary":"Osteoarthritis: New trial drug has powerful anti-inflammatory effect - Medical News Today","headline":"Osteoarthritis: New trial drug has powerful anti-inflammatory effect","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQWFpmWTFuMzhjNU4yVGVrQVRZV0RJMjlWQTRwM1BrSVFhQzlORWIzbVRFS3VGMjVlcHNKLTJHeVhyWDJkcnNCZXlsRl92UXpKWThaZGRfVml6SjBQTVJjLVRJS0d2N0dWZ0J0bEx2NE5zRTZuX2pMdWt3Nk1ENktaeFdWVUNycWo5ZjdnS1NtZExDVHNkdVRYbHZQR0p2QVBTcGJaOUl3TlJYdG8?oc=5","date":"2019-04-24","type":"trial","source":"University of Liverpool","summary":"Next stage of innovative osteoarthritis drug clinical trial begins - University of Liverpool","headline":"Next stage of innovative osteoarthritis drug clinical trial begins","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQWk85dmc5WVBzSnlPWDNWa0trYzVHbUZlSFkweW9hN0x4aDcxVV9kcXBfWWNYdHhaRW5JcFFQaFVoMmdvejFNWTFXVHRwUTVleF9nUUV3RmI4ZEhPM2NuemtTNUhHdGNxd1Bvd3RSMmNVWWkxZ0w5elpPd2laM0ZiXzZIaDdoSUtRQ0hzaXpTdVl5SFY5d2RYWWtjU1pER3NBWmlr?oc=5","date":"2019-02-18","type":"trial","source":"University of Liverpool","summary":"£675k boost for innovative osteoarthritis drug clinical trial - University of Liverpool","headline":"£675k boost for innovative osteoarthritis drug clinical trial","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}